echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Bronchial tumors, multi-organ invasions! But not malignant, not benign...

    Bronchial tumors, multi-organ invasions! But not malignant, not benign...

    • Last Update: 2022-10-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *For medical professionals only



    What exactly is this disease?




    New bronchial organisms, accompanied by tumors of the same type in other organs, are generally malignant tumor invasions
    .
    However, today I share with you a miraculous case
    .
    This tumor will invade many organs, but it is not a malignant tumor, and it is difficult to say that it is a benign tumor
    .


    What is the magic disease?




    Case introduction 39-year-old female with dry cough for 2 years
    .
    Current medical history: dry cough for 2 years, occasional wheezing, denial of symptoms of runny nose, conjunctivitis, postnasal drip or reflux, denial of recent weight loss, hemoptysis, fever, chills, night sweats, denial of fatigue, easy bruising, muscle weakness or thinning of
    the skin 。 Previous history: systemic lupus erythematosus with end-stage renal disease, 16-year prior kidney transplantation, immunosuppressive regimen: prednisone 5 mg once daily, tacrolimus 3 mg once daily, mycophenolate mofetil 500 mg once daily; Prevention of infection: valacyclovir 500 mg 2 times a day; Treatment of hypertension: clonidine 0.
    1 mg once a day, metoprolol 100 mg 2 times
    a day.
    Never smoke.

    No history of
    international travel.
    Physical examination: normal vital signs, oxygen saturation in the breathing chamber air 97%, clear consciousness, no rash, no jugular venous distension, no obvious abnormalities on cardiac examination, lung auscultation shows a slight inspiratory wheezing sound in the left dorsal lobe, no lower extremity edema, no cyanosis
    .
    Adjunctive examination: CT of the chest shows a left lower lobe bronchial nodule
    .
    Figure 1
    CT of the abdomen shows an adrenal nodule
    .
    Figure 2
    Bronchoscopy shows a new organism with a bronchial opening in the lower left lobe
    .
    Figure 3
    Bronchial neoorganism + adrenal nodules, in general, highly suggestive of malignant metastasis
    .
    Will patients with long-term oral immunosuppressants be a special infection?


    Diagnosis and treatment process















    A hard bronchoscopy is performed, and the electric snare device completely excises the new organism
    .


    Figure 4


    Left-sided adrenalectomy
    .


    In situ hybridization of bronchial neoorganisms detected small RNAs encoded by Epstein-Barr virus, and bronchial neoorganisms + adrenal specimens pathology showed leiomyoma
    .


    Final diagnosis: Epstein-Barr virus-associated leiomyomas involve both the bronchial lining and the adrenal glands
    .




    Epstein-Barr virus-associated leiomyoma, benign? Malignant?

    Epstein-Barr virus-associated leiomyomas (EBV SMTs) are rare mesenchymal tumors found only in immunocompromised hosts and are divided into three separate clinicopathological subtypes depending on the cause of immunodeficiency: HIV-related, post-transplant, and congenital immunodeficiency-associated leiomyomas
    .


    Angstrovirus-associated leiomyomas after organ transplantation, which usually appear later, have a median time of 4 years after transplantation, about 50% are multi-organ invasions, and are more likely to develop tumors in organs with less smooth muscle, with kidney transplantation most likely to appear
    .
    Serologic testing is useless, and the most reliable is that in situ hybridization detects small RNAs encoded by EBV (not simply EBV is detected
    ).


    Berke-associated leiomyoma after organ transplantation, it is unclear whether it is benign or malignant
    .
    There is no correlation
    between the histological presentation of the tumor and the clinical outcome.
    Instead, studies have shown that the biological behavior of a tumor depends on the patient's immune status, not on the histological characteristics
    of the tumor.


    Because the disease is so rare, there is no recognized optimal treatment
    .
    It is recommended to first improve the patient's immune function
    .
    When the tumor impairs organ function, surgery or endoscopic resection should be performed
    .
    In some cases, chemoradiation has been shown to be effective
    .
    Overall, the prognosis is good, and few patients die from the direct effects
    of the tumor.
    Poor prognosis is mainly associated
    with intracranial symptoms and unresectable tumors.




    Follow

    After resection, the patient's immunosuppressive regimen
    is adjusted.
    The patient's chronic cough disappears
    .
    CT follow-up of 3 months after surgery showed no signs of
    tumor recurrence.
    If renal function deteriorates again, another kidney transplant
    is necessary.







    More practical knowledge of respiratory practice? Come to the "Doctor Station APP" to take a look 👇

    References:

    [1] Harpreet,et al.
    A 39-Year-Old Woman With Synchronous Endobronchial and Adrenal Tumors.
    [J].
    Chest,2021,160(6):e629-e632.
    DOI:10.
    1016/j.
    chest.
    2021.
    07.
    028.
    Source of this article: Medical Respiratory Channel This article author: Sun Danxiong Responsible editor: Peng Jianping Dai Dai
    copyright declaration
    original This article reprint, please contact the authorization- End - Call for "Medical Respiratory Channel" Long-term recruitment online author, 1.
    Respiratory Medicine Clinical Practical and interesting content; 2.
    Interesting diagnosis and treatment stories of respiratory physicians; 3.
    Heavy progress in the respiratory medicine industry; 4.
    Others (content of interest to the respiratory physician is sufficient).



    Welcome to share the manuscript! We will provide you with competitive fees and a platform
    to showcase your talents.
    Submission Email: daijiaxing@yxj.
    org.
    cn (Submissions must be replied to)
    * The medical community strives to be accurate and reliable in the review of the published content, but does not make any commitment and guarantee as to the timeliness of the published content, as well as the accuracy and completeness of the cited materials (if any), nor does it assume any responsibility
    arising from the fact that such content is outdated, the cited materials may be inaccurate or incomplete, etc.
    Relevant parties are invited to verify separately when adopting or using this as a basis for decision-making
    .

    ↓↓↓ Click "Read the original article" to learn more clinical skills


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.